Niagen Bioscience Inc (NAGE)

CapEx to Revenue

0.30%

Quarterly · Period ending:

NAGE logo

NAGE CapEx to Revenue

Latest reported0.30%
NAGE Quarterly CapEx/Revenue (0.00% → 0.30%)
High-resolution chart · PNG

NAGE capex to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Niagen Bioscience Inc CapEx to Revenue — Quarterly
Period endingCapEx to Revenue
0.2988%
0.1938%
0.2985%
0.0706%
0.4338%
0.105%
0.2369%
0.1603%
0.0528%
0.1851%
0.0991%
0.1334%
0.0492%
0.4034%
0.8192%
0.3048%
0.508%
0.1449%
0.0113%
0.5547%
1.4973%
0.3133%
0.1489%
0.409%
0.6018%
0.1046%
2.1392%
1.286%
0.6216%
2.4781%
1.0588%
1.0099%
14.2637%
2.4517%
3.9211%
9.4839%
3.1532%
10.2732%
10.2611%
18.281%
4.4688%
0.4314%
6.8156%
2.9997%
0.9979%
1.9156%
2.5846%
1.2092%
1.9124%
0.5942%
1.6585%
3.9553%
1.1668%
2.0316%
0.3066%
1.4192%
0.2808%
0.3761%
1.3438%
1.8831%
3.0579%
2.3114%
2.1833%
2.9002%
1.1393%
4.4528%
9.4909%
0.8084%
1.0622%
0.7643%
6.1605%
11.4758%
0%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.